Toll-Like Receptor 4 Activation in Cancer Progression and Therapy

Keywords

Tribunal, Political science, Humanities, Art, Law

References

• Developmental control of endocytosis in dendritic cells by Cdc42.John N. Ridgely, R.K. Cole, Randall O. Gauntt — 2000
• Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 41Geoffrey B. Johnson, Gregory J. Brunn, Yuzo Kodaira — 2002
• MD-2 binds to bacterial lipopolysaccharide.Suganya Viriyakosol, Peter S. Tobias, Richard L. Kitchens — 2001
• Intracellular expression of toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharideFerdaus Hassan, Shamima Islam, Gantsetseg Tumurkhuu — 2006
• Bacillus Calmette–Guérin treatment of non‐muscle invasive bladder cancerRichard Sylvester — 2011
• Cutting Edge: The Immunostimulatory Activity of the Lung Surfactant Protein-A Involves Toll-Like Receptor 41Loïc Guillot, Viviane Balloy, Francis X. McCormack — 2002
• IL-6 Prevents T Cell-Mediated Hepatitis via Inhibition of NKT Cells in CD4+ T Cell- and STAT3-Dependent MannersRui Sun, Zhigang Tian, Shalini Kulkarni — 2004
• Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results.Christopher W. Cluff — 2010
• Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex1Koji Ohashi, Volker Burkart, Stefanie B. Flohé — 2000
• Low Molecular Weight Hyaluronic Acid Increases the Self-Defense of Skin Epithelium by Induction of β-Defensin 2 via TLR2 and TLR4Silvia Gariboldi, Marco Palazzo, Laura Zanobbio — 2008
• Biological effect of OK-432 (picibanil) and possible application to dendritic cell therapy.Yoshiki Ryoma, Yoichiro Moriya, Masato Okamoto — 2004
• Toll-like Receptor 4 Activation Increases Akt Phosphorylation in Colon Cancer CellsHung Q. Doan, Kanika A. Bowen, Lindsey A. Jackson — 2009
• TLR4‐mediated skin carcinogenesis is dependent on immune and radioresistant cellsDeepak Mittal, Fabiana Saccheri, Emilie Vénéreau — 2010
• The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein.Carl Hashimoto, Kathy Hudson, Kathryn V. Anderson — 1988
• High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancerE L Wang, Zhi Rong Qian, Masahiko Nakasono — 2010
• The hallmarks of cancerTony Gutschner, Sven Diederichs — 2012
• Toll-like receptor expression in normal ovary and ovarian tumorsMingfu Zhou, Molly M. McFarland-Mancini, Holly M. Funk — 2009
• Enhanced Dendritic Cell Antigen Capture via Toll-Like Receptor-Induced Actin RemodelingMichele West, Robert P. A. Wallin, S. Matthews — 2004
• Enhancement of antitumor effect using dendritic cells activated with natural killer cells in the presence of Toll-like receptor agonistThanh Nhan Nguyen Pham, Cheol Yi Hong, Jung-Joon Min — 2010
• The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages.Liliana Schaefer, Andrea Bábelová, Éva Kiss — 2005

Cited by

• siRNA and cancer immunotherapy.David Burdette — 2012
• Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effectsSusanna Portell, Isabel Muntané — 2015
• TLR4 siRNA inhibits proliferation and invasion in colorectal cancer cells by downregulating ACAT1 expression.Larissa B. Shapkina, Adolph A. Leonovich, Michael K. Nikitin — 2016
• Immunopharmacology of Lipid A MimeticsWilliam S. Bowen, Siva K. Gandhapudi, Joseph P. Kolb — 2013
• TLR4-MyD88-TRAF6-TAK1 Complex-Mediated NF-κB Activation Contribute to the Anti-Inflammatory Effect of V8 in LPS-Induced Human Cervical Cancer SiHa CellsAiqin He, Rui Ji, Jia Shao — 2016
• TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cellsSumeet Jain, Sujit Suklabaidya, Biswajit Das — 2015
• HIF-1 at the crossroads of hypoxia, inflammation, and cancerKuppusamy Balamurugan — 2015
• Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongueJoonas H. Kauppila, A. Mattila, Tuomo J. Karttunen — 2013
• Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasisInés Omrane, Olfa Baroudi, Nadia Kourda — 2013
• Biological role of Toll-like receptor-4 in the brain.Teresa Trotta, Chiara Porro, Rosa Calvello — 2014
• Drying enhances immunoactivity of spent brewer's yeast cell wall β-D-glucans.Jānis Liepiņš, E Kováčová, Karlis Shvirksts — 2015
• Trial WatchJonathan Pol, Norma Bloy, Florine Obrist — 2013
• Epigenetic Regulation of Toll-Like Receptor Signaling: Implications for Cancer DevelopmentShannon K. Boi, Sherine F. Elsawa — 2013
• Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancersMallikarjuna Rao Pichika, Chun‐Wai Mai, Yew Beng Kang — 2013
• Association between Toll-like receptor 3 polymorphisms and cancer risk: a meta-analysisDaye Cheng, Yiwen Hao, Wenling Zhou — 2014
• TLR4-dependant immune response, but not hepatitis B virus reactivation, is important in radiation-induced liver disease of liver cancer radiotherapyZhifeng Wu, Xiaohui Zhou, Yunwen Hu — 2014
• A magnetic switch for the control of cell death signalling in in vitro and in vivo systems.Mi Hyeon Cho, Eun Jung Lee, Mina Son — 2012
• HMGB1 in Hormone-Related Cancer: a Potential Therapeutic TargetMadhuwanti Srinivasan, Souresh Banerjee, Allison Palmer — 2014
• Trial watchErika Vacchelli, Isabelle Martins, Alexander Eggermont — 2012
• Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.Joonas H. Kauppila, Johanna Korvala, Kristiina Siirilä — 2015

Related papers

No related papers recorded.